Eczema &
recurrent boils
| Topical antiseptics, e.g., dilute bleach baths 1 & chlorhexidine; frequent swimming in chlorinated pool | Adequate skin lubrication is needed after bleach. |
Anti-staphylococcal prophylaxis, e.g., w/2x/day TMP/SMX | |
Histamine-1 antagonists (e.g., hydroxyzine) to control pruritus | Helpful for more significant eczema |
Recurrent
pneumonias
| Antibiotic prophylaxis, typically w/2x/day TMP/SMX | Targeting Staphylococcus aureus & other pyogenic bacteria to prevent the pneumonias & their complications |
In Coccidioides endemic regions use of prophylactic antifungals (e.g., fluconazole) can be considered. | To prevent disseminated severe infection |
If structural damage to the lungs (e.g., bronchiectasis &/or pneumatoceles) has occurred, the breadth of antimicrobial coverage may need to be extended, incl antifungals, as these structural abnormalities become secondarily infected w/gram-negative bacteria (e.g., Pseudomonas) or fungi (e.g., Aspergillus). In the setting of bronchiectasis, consideration of azithromycin to prevent exacerbations if no mycobacterial infection present
| Sputum samples for bacteria, fungi, & mycobacteria (typically nontuberculous) should be obtained for microbiology during lung infections to help guide antimicrobial choice. |
Intravenous or subcutaneous IgG replacement can be considered. | Has been used w/anecdotal improvement for some individuals, esp those who fail to make protective levels of specific antibodies following vaccination challenge; prospective, randomized controlled studies of immunoglobulin supplementation have not been performed. |
Airway clearance w/bronchiectasis | Airway clearance techniques incl airway clearance devices, hypertonic saline nebulizers. |
Chronic mucocutaneous
candidiasis
| Antifungal prophylaxis | Consider fluconazole prophylaxis if living in a Coccidioides endemic region. |
Osteoporosis &
Minimal trauma
fractures
| Optimize calcium & vitamin D intake | The role of bisphosphonates for those w/this disorder w/osteoporosis is unclear; some improvement seen in bone density but unclear improvement in fractures [Sowerwine et al 2014]. |
Arterial
aneurysms
| Optimal blood pressure mgmt | |
Antiplatelet or anticoagulation therapies may be considered for individuals w/significant coronary artery aneurysms to prevent myocardial infarction related to clotting w/in the aneurysm. | This must be weighed against risk of hemoptysis, a complication of fungal or bacterial lung disease in persons w/STAT3-HIES. |